CNR1 and experimental autoimmune encephalomyelitis: Preclinical studies in the experimental autoimmune encephalomyelitis (EAE) mouse model demonstrated that treatment with CBD and THC decreases axonal damage, inflammation, microglial activation, and T-cell recruitment, leading to a symptomatic improvement that seems to be related to direct action on the CB1R [55,56].